Pneumomédiastin spontané : une complication rare du COVID-19 ?

Underner, M.; Peiffer, G.; Perriot, J.; Jaafari, Nemat

doi:10.1016/j.rmr.2020.06.013

Cited by 6 publications

(5 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[7][8][9] Many risk factors are involved in the development of intrathoracic gas effusions, including tobacco, drug addiction (cocaine), persistent cough, asthma, chronic obstructive pulmonary disease, and mechanical ventilation. [10][11][12] In our patients, the occurrence of gas effusions was spontaneous in the absence of any invasive or noninvasive mechanical ventilation. Cough related to COVID-19 pneumonia and smoking (77.8% and 55.5%, respectively) were the most frequent risk factors in our study.…”

Section: Discussionmentioning

confidence: 99%

Intrathoracic gas effusions in patients with COVID-19

et al. 2023

View full text Add to dashboard Cite

Current evidence suggests that intrathoracic gas effusions (pneumomediastinum and pneumothorax) may be observed among COVID-19 patients even without mechanical ventilation. Here, we report 9 patients who developed spontaneous intrathoracic gas effusions in the absence of mechanical ventilation. The incidence of spontaneous intrathoracic gas effusions is low at 0.5% in hospitalized COVID-19 patients in the absence of respiratory support. Two patients (22.2%) had spontaneous pneumomediastinum, with or without subcutaneous emphysema. Three patients (33.3%) had pneumomediastinum associated with pneumothorax, with or without subcutaneous emphysema, and 4 patients (44.4%) had spontaneous pneumothorax. The Pneumothorax was unilateral in 66.6% of cases (6/9) but without location preference. Five of our patients were smokers, of whom 80% had isolated spontaneous pneumothorax. Other comorbidities included pulmonary tuberculosis in a single patient, diabetes in 2 patients and arterial hypertension in 1 patient. None of the patients had respiratory comorbidities. All of our patients were male. The average duration of hospital stay was 10 days (±6.63). All patients required oxygen therapy. Three patients (33.3%) with spontaneous pneumothorax required chest drainage. The evolution was favorable in 6 patients (66.7%) and worse in 3 cases (33.3%). The respiratory manifestations of COVID-19 have been stereotyped. Intrathoracic effusions may also be signs of COVID-19 with varying prognoses, or even the only presentation of the disease. This should be considered in clinical practice, and doctors are encouraged to request a SARS-CoV-2 test in this situation. Further investigations with a larger sample size are needed to identify the prognostic factors in COVID-19 patients with gas effusions.

show abstract

Section: Discussionmentioning

confidence: 99%

Intrathoracic gas effusions in patients with COVID-19

et al. 2023

View full text Add to dashboard Cite

show abstract

“…All of the patients at our institution were in respiratory distress with an increased need for oxygen supplementation, which prompted the need for additional chest imaging. Physical examination may demonstrate crepitations in the cervical region on auscultation (Hamman's sign) and palpation [9], particularly when there is concurrent subcutaneous emphysema. Vital signs may indicate tachycardia, tachypnea, or hypotension.…”

Section: Discussionmentioning

confidence: 99%

Isolated Spontaneous Pneumomediastinum in COVID-19 Patients: Case Series and Review of the Literature

Chen¹,

Roth²,

Thomas³

et al. 2021

J Med Imaging Case Rep

View full text Add to dashboard Cite

While isolated spontaneous pneumomediastinum (SPM) is not commonly associated with viral respiratory infections, several cases of isolated SPM in the context of coronavirus disease 2019 (COVID-19) have emerged. Isolated SPM remains seldom presented in the current literature. We will present the clinical presentation and hospital course of isolated SPM in four patients hospitalized with COVID-19 who were not on mechanical ventilation. We will also review all cases from the current literature and compare these cases for similarities and possible patterns that may help elucidate risk factors for developing SPM. Increased use of high-flow oxygen in COVID-19 management may be a potential contributing factor to the SPM development. Isolated SPM can be an indicator of disease severity and worse prognosis.

show abstract

“…Bien que l'atteinte parenchymateuse soit la plus fréquente, il existe plusieurs présentations cliniques dont des pneumomédiastins [ 1 , 2 ].…”

Section: Introductionunclassified

Dégradation respiratoire et COVID-19… Et si c’était un pneumomédiastin ?

Ghrenassia

Nguyen²,

Carte³

2022

M�decine et Maladies Infectieuses Formation

View full text Add to dashboard Cite

La pneumopathie à SARS-Cov-2, dont les premiers cas sont apparus en Chine en novembre 2019, est à l'origine d'une pandémie mondiale depuis le mois de mars 2020. À son atteinte du parenchyme pulmonaire connue et majoritaire, s'ajoutent d'autres anomalies thoraciques dont des pneumomédiastins, plus rarement décrits. Nous rapportons deux cas de pneumomédiastins spontanés chez deux patients qui n'avaient pas été traités par une ventilation mécanique. Bien que ne semblant pas avoir d'incidence sur le pronostic de la maladie, un pneumomédiastin est à rechercher chez le patient atteint de pneumopathie à SARS-Cov-2 devant une majoration de la dyspnée, l'apparition d'un emphysème sous-cutané, ou l'apparition d'une douleur thoracique.

show abstract

Pneumomédiastin spontané : une complication rare du COVID-19 ?

Cited by 6 publications

References 22 publications

Intrathoracic gas effusions in patients with COVID-19

Intrathoracic gas effusions in patients with COVID-19

Isolated Spontaneous Pneumomediastinum in COVID-19 Patients: Case Series and Review of the Literature

Dégradation respiratoire et COVID-19… Et si c’était un pneumomédiastin ?

Contact Info

Product

Resources

About